Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of urticaria: a consensus report.

T Zuberbier1, M W Greaves, L Juhlin

  • 1Department of Dermatology and Allergy, Charité, Humboldt University, Berlin, Germany. torsten.zuberbier@charite.de

The Journal of Investigative Dermatology. Symposium Proceedings
|January 5, 2002
PubMed
Summary

Effective urticaria treatment requires H1 antihistamines, potentially at higher doses. Alternative therapies may be needed for varied patient responses and subtypes, avoiding long-term immunosuppressants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pioneers in Dermatology and Venereology: an interview with Professor Georg Stingl.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Single-cell RNA sequencing profiling in a patient with discordant primary cutaneous B-cell and T-cell lymphoma reveals micromilieu-driven immune skewing.

The British journal of dermatology·2021
Same author

Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics.

The British journal of dermatology·2017
Same author

IgE autoreactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants.

The British journal of dermatology·2017
Same author

Molecular classification of tumour cells in a patient with intravascular large B-cell lymphoma.

The British journal of dermatology·2017
Same author

Pru p 3, a marker allergen for lipid transfer protein sensitization also in Central Europe.

Allergy·2017

Area of Science:

  • Dermatology and immunology, focusing on cutaneous conditions.

Background:

  • Urticaria significantly impacts patient quality of life, necessitating effective therapeutic strategies.
  • Consensus reached during the International Clinically Oriented ESDR Symposium Urticaria 2000 highlights treatment needs.

Framework:

  • The primary treatment recommendation involves nonsedating H1 antihistamines.
  • Evidence supports their efficacy in double-blind, placebo-controlled studies.

Implementation:

  • Higher than standard doses of H1 antihistamines may be required for optimal patient outcomes.
  • Individual variations in urticaria subtypes and treatment response necessitate consideration of alternative therapies.

Implications:

  • Long-term use of immunosuppressive agents such as cyclosporine A and corticosteroids is discouraged due to potential adverse effects.

Related Experiment Videos

  • Personalized treatment approaches are crucial for managing chronic urticaria effectively.